172 related articles for article (PubMed ID: 26358405)
1. Efficient refolding of the bifunctional therapeutic fusion protein VAS-TRAIL by a triple agent solution.
Fan J; Wang Z; Huang L; Shen Y
Protein Expr Purif; 2016 Sep; 125():68-73. PubMed ID: 26358405
[TBL] [Abstract][Full Text] [Related]
2. Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity.
Fan J; Huang L; Sun J; Qiu Y; Zhou J; Shen Y
J Biotechnol; 2015 Sep; 209():16-22. PubMed ID: 26072465
[TBL] [Abstract][Full Text] [Related]
3. A simplified method for the efficient purification and refolding of recombinant human TRAIL.
Zhang Z; Hahn SB; Cao TM; King MR
Biotechnol Prog; 2020 Sep; 36(5):e3007. PubMed ID: 32329219
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
[TBL] [Abstract][Full Text] [Related]
5. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Wang D; Shi L
Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
[TBL] [Abstract][Full Text] [Related]
6. Engineering and refolding of a novel trimeric fusion protein TRAIL-collagen XVIII NC1.
Pan LQ; Xie ZM; Tang XJ; Wu M; Wang FR; Naranmandura H; Chen SQ
Appl Microbiol Biotechnol; 2013 Aug; 97(16):7253-64. PubMed ID: 23208613
[TBL] [Abstract][Full Text] [Related]
7. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
Upadhyay V; Singh A; Jha D; Singh A; Panda AK
Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
9. A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form.
Qi X; Sun Y; Xiong S
Microb Cell Fact; 2015 Feb; 14():24. PubMed ID: 25879903
[TBL] [Abstract][Full Text] [Related]
10. Recombinant production of biologically active giant grouper (Epinephelus lanceolatus) growth hormone from inclusion bodies of Escherichia coli by fed-batch culture.
Chung WJ; Huang CL; Gong HY; Ou TY; Hsu JL; Hu SY
Protein Expr Purif; 2015 Jun; 110():79-88. PubMed ID: 25703054
[TBL] [Abstract][Full Text] [Related]
11. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
Kang H; Sun AY; Shen YL; Wei DZ
Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase.
Gasparian ME; Ostapchenko VG; Yagolovich AV; Tsygannik IN; Chernyak BV; Dolgikh DA; Kirpichnikov MP
Biotechnol Lett; 2007 Oct; 29(10):1567-73. PubMed ID: 17609857
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.
Singh SM; Sharma A; Upadhyay AK; Singh A; Garg LC; Panda AK
Protein Expr Purif; 2012 Jan; 81(1):75-82. PubMed ID: 21964443
[TBL] [Abstract][Full Text] [Related]
14. Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus.
Rosa da Silva CM; Chura-Chambi RM; Ramos Pereira L; Cordeiro Y; de Souza Ferreira LC; Morganti L
BMC Biotechnol; 2018 Dec; 18(1):78. PubMed ID: 30541520
[TBL] [Abstract][Full Text] [Related]
15. Solubilization and refolding of bacterial inclusion body proteins.
Singh SM; Panda AK
J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
[TBL] [Abstract][Full Text] [Related]
16. Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive.
Kudou M; Ejima D; Sato H; Yumioka R; Arakawa T; Tsumoto K
Protein Expr Purif; 2011 May; 77(1):68-74. PubMed ID: 21195184
[TBL] [Abstract][Full Text] [Related]
17. Target cell-restricted apoptosis induction by 528scFv-TRAIL fusion protein specific for human EGFR and expressed in Escherichia coli.
Badran A; Asano R; Nakayama M; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kumagai I
Int J Oncol; 2010 May; 36(5):1229-34. PubMed ID: 20372797
[TBL] [Abstract][Full Text] [Related]
18. Improving the refolding efficiency for proinsulin aspart inclusion body with optimized buffer compositions.
Chen Y; Wang Q; Zhang C; Li X; Gao Q; Dong C; Liu Y; Su Z
Protein Expr Purif; 2016 Jun; 122():1-7. PubMed ID: 26826314
[TBL] [Abstract][Full Text] [Related]
19. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process.
Freydell EJ; van der Wielen LA; Eppink MH; Ottens M
Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819
[TBL] [Abstract][Full Text] [Related]
20. Solubilization and refolding with simultaneous purification of recombinant human stem cell factor.
Wang C; Liu J; Wang L; Geng X
Appl Biochem Biotechnol; 2008 Feb; 144(2):181-9. PubMed ID: 18456949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
